

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.25465706 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.13667622 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.13667622 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.13667622 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.13667622 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.13667622 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.13667622 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.39921335 |
| 9 | response to peptidoglycan (GO:0032494) | 4.09880676 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 4.07841221 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.00223974 |
| 12 | detection of other organism (GO:0098543) | 3.95948642 |
| 13 | detection of bacterium (GO:0016045) | 3.78310764 |
| 14 | mannose metabolic process (GO:0006013) | 3.74789033 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.72438632 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.60926346 |
| 17 | negative regulation of cell killing (GO:0031342) | 3.60926346 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 3.58846881 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.58059882 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.58059882 |
| 21 | positive regulation of histone deacetylation (GO:0031065) | 3.53481981 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.51315777 |
| 23 | positive regulation of p38MAPK cascade (GO:1900745) | 3.48941656 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.48435073 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.46498392 |
| 26 | negative regulation of granulocyte differentiation (GO:0030853) | 3.45820504 |
| 27 | regulation of mast cell degranulation (GO:0043304) | 3.43778587 |
| 28 | positive regulation of interferon-alpha production (GO:0032727) | 3.43032976 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 3.37830769 |
| 30 | regulation of interferon-alpha production (GO:0032647) | 3.31352976 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 3.31329894 |
| 32 | regulation of integrin activation (GO:0033623) | 3.28552388 |
| 33 | pinocytosis (GO:0006907) | 3.25112616 |
| 34 | response to host immune response (GO:0052572) | 3.23993859 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.23993859 |
| 36 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.21690945 |
| 37 | positive thymic T cell selection (GO:0045059) | 3.21488286 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.19033924 |
| 39 | apoptotic cell clearance (GO:0043277) | 3.18641636 |
| 40 | regulation of cholesterol storage (GO:0010885) | 3.15658505 |
| 41 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.10917077 |
| 42 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.08896354 |
| 43 | low-density lipoprotein particle clearance (GO:0034383) | 3.08007848 |
| 44 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.07618665 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.06788104 |
| 46 | response to host (GO:0075136) | 3.06788104 |
| 47 | response to host defenses (GO:0052200) | 3.06788104 |
| 48 | detection of biotic stimulus (GO:0009595) | 3.04592127 |
| 49 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.02747219 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.99780623 |
| 51 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.95538890 |
| 52 | regulation of mast cell activation (GO:0033003) | 2.93587075 |
| 53 | I-kappaB phosphorylation (GO:0007252) | 2.93393064 |
| 54 | negative regulation of interleukin-12 production (GO:0032695) | 2.92989651 |
| 55 | response to laminar fluid shear stress (GO:0034616) | 2.92530202 |
| 56 | microglial cell activation (GO:0001774) | 2.92464826 |
| 57 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.89830899 |
| 58 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.88880528 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 2.86173229 |
| 60 | NLS-bearing protein import into nucleus (GO:0006607) | 2.80982249 |
| 61 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.79773053 |
| 62 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.78252705 |
| 63 | natural killer cell mediated immunity (GO:0002228) | 2.78252705 |
| 64 | response to type I interferon (GO:0034340) | 2.78022649 |
| 65 | respiratory burst (GO:0045730) | 2.76145621 |
| 66 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.75441062 |
| 67 | cellular response to type I interferon (GO:0071357) | 2.74097127 |
| 68 | type I interferon signaling pathway (GO:0060337) | 2.74097127 |
| 69 | pre-miRNA processing (GO:0031054) | 2.73761343 |
| 70 | regulation of B cell differentiation (GO:0045577) | 2.72972785 |
| 71 | positive regulation of mast cell activation (GO:0033005) | 2.72671804 |
| 72 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.68893265 |
| 73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.68825095 |
| 74 | defense response to protozoan (GO:0042832) | 2.68648340 |
| 75 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.68623050 |
| 76 | positive regulation of antigen processing and presentation (GO:0002579) | 2.67867869 |
| 77 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.67612853 |
| 78 | regulation of T cell tolerance induction (GO:0002664) | 2.67120706 |
| 79 | regulation of regulated secretory pathway (GO:1903305) | 2.65964361 |
| 80 | regulation of p38MAPK cascade (GO:1900744) | 2.64526929 |
| 81 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.64214833 |
| 82 | positive regulation of interferon-beta production (GO:0032728) | 2.63942926 |
| 83 | neutrophil activation involved in immune response (GO:0002283) | 2.63082353 |
| 84 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.60557391 |
| 85 | response to interleukin-15 (GO:0070672) | 2.60447824 |
| 86 | positive regulation of protein deacetylation (GO:0090312) | 2.59955900 |
| 87 | negative regulation of stress fiber assembly (GO:0051497) | 2.59735196 |
| 88 | regulation of tolerance induction (GO:0002643) | 2.59512940 |
| 89 | response to protozoan (GO:0001562) | 2.59453774 |
| 90 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.58852726 |
| 91 | detection of molecule of bacterial origin (GO:0032490) | 2.58310304 |
| 92 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.57687322 |
| 93 | negative regulation of interleukin-6 production (GO:0032715) | 2.56185117 |
| 94 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.54954603 |
| 95 | negative regulation of type 2 immune response (GO:0002829) | 2.54324760 |
| 96 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.54087021 |
| 97 | negative regulation of phagocytosis (GO:0050765) | 2.53354047 |
| 98 | negative regulation of innate immune response (GO:0045824) | 2.51622037 |
| 99 | macrophage activation (GO:0042116) | 2.51283066 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51166942 |
| 101 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.49659089 |
| 102 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.49381982 |
| 103 | positive regulation of mast cell degranulation (GO:0043306) | 2.49381982 |
| 104 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.49250407 |
| 105 | B cell homeostasis (GO:0001782) | 2.47532937 |
| 106 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.47264790 |
| 107 | negative regulation of B cell proliferation (GO:0030889) | 2.47044229 |
| 108 | lipoprotein transport (GO:0042953) | 2.45566740 |
| 109 | B cell mediated immunity (GO:0019724) | 2.44438097 |
| 110 | response to UV-C (GO:0010225) | 2.43564542 |
| 111 | negative thymic T cell selection (GO:0045060) | 2.43299888 |
| 112 | negative regulation of interleukin-8 production (GO:0032717) | 2.42220256 |
| 113 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.41725602 |
| 114 | cellular response to interleukin-15 (GO:0071350) | 2.41541564 |
| 115 | neutrophil activation (GO:0042119) | 2.41329399 |
| 116 | regulation of antigen processing and presentation (GO:0002577) | 2.40747201 |
| 117 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.40532132 |
| 118 | myeloid leukocyte activation (GO:0002274) | 2.40215363 |
| 119 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.40178055 |
| 120 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.40178055 |
| 121 | leukocyte degranulation (GO:0043299) | 2.39473147 |
| 122 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.39385985 |
| 123 | myeloid cell activation involved in immune response (GO:0002275) | 2.39222709 |
| 124 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.38560751 |
| 125 | T-helper 1 type immune response (GO:0042088) | 2.38469932 |
| 126 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.38447265 |
| 127 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.38344756 |
| 128 | NIK/NF-kappaB signaling (GO:0038061) | 2.38278499 |
| 129 | negative regulation of histone methylation (GO:0031061) | 2.37240317 |
| 130 | granulocyte activation (GO:0036230) | 2.37062513 |
| 131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.35484505 |
| 132 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.35315489 |
| 133 | tolerance induction (GO:0002507) | 2.34841766 |
| 134 | cellular extravasation (GO:0045123) | 2.34359900 |
| 135 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.33586039 |
| 136 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.32819378 |
| 137 | neutrophil mediated immunity (GO:0002446) | 2.32002017 |
| 138 | response to muramyl dipeptide (GO:0032495) | 2.30328451 |
| 139 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.30219760 |
| 140 | germinal center formation (GO:0002467) | 2.28474276 |
| 141 | embryonic placenta development (GO:0001892) | 2.28194743 |
| 142 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.26937971 |
| 143 | regulation of granulocyte differentiation (GO:0030852) | 2.26531855 |
| 144 | regulation of interferon-beta production (GO:0032648) | 2.25864286 |
| 145 | response to fluid shear stress (GO:0034405) | 2.25146664 |
| 146 | regulation of phagocytosis (GO:0050764) | 2.23519758 |
| 147 | leukocyte aggregation (GO:0070486) | 2.23460655 |
| 148 | modulation by symbiont of host cellular process (GO:0044068) | 2.23377611 |
| 149 | thymic T cell selection (GO:0045061) | 2.22472201 |
| 150 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.22017641 |
| 151 | regulation of leukocyte degranulation (GO:0043300) | 2.21676049 |
| 152 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.21352726 |
| 153 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.20813299 |
| 154 | regulation of superoxide anion generation (GO:0032928) | 2.20518876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.59596973 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.45738072 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.40627698 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.33563936 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.16272632 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.08211583 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.07364670 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.71604474 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70888949 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.62399960 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.62006735 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57446121 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53594416 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.31230554 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.25693505 |
| 16 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.14322737 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.13326925 |
| 18 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05217953 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01852800 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97995895 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 1.96892441 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 1.94375613 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94346040 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.91791623 |
| 25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90887935 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.90626329 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.85832298 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.83114550 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77399141 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.77198118 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.76858851 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67905813 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66429559 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66390876 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.65323432 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64976874 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.63691331 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.62660397 |
| 39 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59654142 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54215014 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.52521951 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52110296 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.51678968 |
| 44 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49424922 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46789195 |
| 46 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45419489 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44045904 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41155989 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40814777 |
| 50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.40238725 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38923570 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37830868 |
| 53 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.37056039 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35662370 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33586814 |
| 56 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.33033385 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30885324 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29718301 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29106252 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28449555 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.26256783 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25880159 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25402112 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23975664 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22281293 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21676383 |
| 67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21222505 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21102918 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20737342 |
| 70 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.18285660 |
| 71 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17796622 |
| 72 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17521644 |
| 73 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17238726 |
| 74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16205789 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15439551 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14257894 |
| 77 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.14164003 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12948039 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12879637 |
| 80 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12878246 |
| 81 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12778396 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11092384 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11017467 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 1.10996618 |
| 85 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10893725 |
| 86 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10665411 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10328370 |
| 88 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09593715 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09282658 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09011747 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08683824 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08579674 |
| 93 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.07429835 |
| 94 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05765258 |
| 95 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.05277802 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04871227 |
| 97 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04858120 |
| 98 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04718228 |
| 99 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04628467 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04605821 |
| 101 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03823566 |
| 102 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02922114 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02103042 |
| 104 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01190060 |
| 105 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00520085 |
| 106 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.00023075 |
| 107 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99604885 |
| 108 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98735740 |
| 109 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.98714415 |
| 110 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97434602 |
| 111 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96244288 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95999745 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95499015 |
| 114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95489643 |
| 115 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94460881 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93799305 |
| 117 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93776346 |
| 118 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93748896 |
| 119 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93697683 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92942748 |
| 121 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92517907 |
| 122 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91734218 |
| 123 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91592120 |
| 124 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91587803 |
| 125 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91305548 |
| 126 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90584243 |
| 127 | P68_20966046_ChIP-Seq_HELA_Human | 0.89492317 |
| 128 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88521941 |
| 129 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86049717 |
| 130 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85942124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.86406791 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.66577220 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.39887526 |
| 4 | MP0003303_peritoneal_inflammation | 3.13135334 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.57724786 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.47888810 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.47274872 |
| 8 | MP0009278_abnormal_bone_marrow | 2.46574707 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.44344291 |
| 10 | MP0003436_decreased_susceptibility_to | 2.29436076 |
| 11 | MP0005076_abnormal_cell_differentiation | 2.24161261 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.23977917 |
| 13 | MP0001800_abnormal_humoral_immune | 2.19618573 |
| 14 | MP0001790_abnormal_immune_system | 2.16218733 |
| 15 | MP0005387_immune_system_phenotype | 2.16218733 |
| 16 | MP0009840_abnormal_foam_cell | 2.12198547 |
| 17 | MP0004510_myositis | 2.09629859 |
| 18 | MP0003566_abnormal_cell_adhesion | 2.08632369 |
| 19 | MP0010307_abnormal_tumor_latency | 2.07374348 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.95609548 |
| 21 | MP0002452_abnormal_antigen_presenting | 1.93970226 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 1.90933623 |
| 23 | MP0002419_abnormal_innate_immunity | 1.82018906 |
| 24 | MP0000685_abnormal_immune_system | 1.78070465 |
| 25 | MP0004185_abnormal_adipocyte_glucose | 1.66328178 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.65597764 |
| 27 | MP0006082_CNS_inflammation | 1.65254551 |
| 28 | MP0002723_abnormal_immune_serum | 1.64274849 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.64135158 |
| 30 | MP0009764_decreased_sensitivity_to | 1.62862601 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.61861445 |
| 32 | MP0004947_skin_inflammation | 1.61795123 |
| 33 | MP0005257_abnormal_intraocular_pressure | 1.61325450 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.58961876 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.58826618 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.58540648 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.58540648 |
| 38 | MP0001819_abnormal_immune_cell | 1.58313938 |
| 39 | MP0002398_abnormal_bone_marrow | 1.53233192 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.52328817 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.51997454 |
| 42 | MP0005025_abnormal_response_to | 1.50925273 |
| 43 | MP0008260_abnormal_autophagy | 1.42362117 |
| 44 | MP0003075_altered_response_to | 1.42297170 |
| 45 | MP0008961_abnormal_basal_metabolism | 1.41516943 |
| 46 | MP0003448_altered_tumor_morphology | 1.40287819 |
| 47 | MP0000716_abnormal_immune_system | 1.39939633 |
| 48 | MP0002405_respiratory_system_inflammati | 1.38315989 |
| 49 | MP0002722_abnormal_immune_system | 1.37013616 |
| 50 | MP0004381_abnormal_hair_follicle | 1.36370282 |
| 51 | MP0005670_abnormal_white_adipose | 1.35714352 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.34097760 |
| 53 | MP0005451_abnormal_body_composition | 1.29946059 |
| 54 | MP0005671_abnormal_response_to | 1.29363819 |
| 55 | MP0004883_abnormal_blood_vessel | 1.27327815 |
| 56 | MP0005164_abnormal_response_to | 1.27012227 |
| 57 | MP0002429_abnormal_blood_cell | 1.22443580 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.22230559 |
| 59 | MP0000371_diluted_coat_color | 1.19585662 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.18078026 |
| 61 | MP0005023_abnormal_wound_healing | 1.17275632 |
| 62 | MP0003045_fibrosis | 1.15704215 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.13745750 |
| 64 | MP0001849_ear_inflammation | 1.13364092 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.13142231 |
| 66 | MP0003866_abnormal_defecation | 1.12829399 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.12794595 |
| 68 | MP0005390_skeleton_phenotype | 1.10605335 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.10370774 |
| 70 | MP0000858_altered_metastatic_potential | 1.09415245 |
| 71 | MP0003279_aneurysm | 1.09218066 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.08710638 |
| 73 | MP0004130_abnormal_muscle_cell | 1.08426925 |
| 74 | MP0001958_emphysema | 1.07694097 |
| 75 | MP0001873_stomach_inflammation | 1.07373639 |
| 76 | MP0008004_abnormal_stomach_pH | 1.07328461 |
| 77 | MP0003690_abnormal_glial_cell | 1.06157370 |
| 78 | MP0003828_pulmonary_edema | 1.05995993 |
| 79 | MP0003091_abnormal_cell_migration | 1.05930000 |
| 80 | MP0000703_abnormal_thymus_morphology | 1.05406882 |
| 81 | MP0000609_abnormal_liver_physiology | 1.04647816 |
| 82 | MP0002006_tumorigenesis | 1.04355729 |
| 83 | MP0003111_abnormal_nucleus_morphology | 1.04068952 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 1.02806088 |
| 85 | MP0009785_altered_susceptibility_to | 1.02308384 |
| 86 | MP0005310_abnormal_salivary_gland | 1.01894422 |
| 87 | MP0005666_abnormal_adipose_tissue | 1.01233293 |
| 88 | MP0005166_decreased_susceptibility_to | 0.99898385 |
| 89 | MP0000733_abnormal_muscle_development | 0.99741290 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.95766839 |
| 91 | MP0000490_abnormal_crypts_of | 0.95285742 |
| 92 | MP0000015_abnormal_ear_pigmentation | 0.92744399 |
| 93 | MP0002998_abnormal_bone_remodeling | 0.92288667 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.91849302 |
| 95 | MP0010329_abnormal_lipoprotein_level | 0.91122532 |
| 96 | MP0000249_abnormal_blood_vessel | 0.89429220 |
| 97 | MP0003329_amyloid_beta_deposits | 0.89317449 |
| 98 | MP0001663_abnormal_digestive_system | 0.88791801 |
| 99 | MP0005375_adipose_tissue_phenotype | 0.87892199 |
| 100 | MP0009115_abnormal_fat_cell | 0.87608355 |
| 101 | MP0008469_abnormal_protein_level | 0.87555091 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.85805907 |
| 103 | MP0003763_abnormal_thymus_physiology | 0.84302503 |
| 104 | MP0005621_abnormal_cell_physiology | 0.81127733 |
| 105 | MP0001915_intracranial_hemorrhage | 0.80727401 |
| 106 | MP0000598_abnormal_liver_morphology | 0.80207449 |
| 107 | MP0002933_joint_inflammation | 0.78472881 |
| 108 | MP0001851_eye_inflammation | 0.77857889 |
| 109 | MP0002019_abnormal_tumor_incidence | 0.77691100 |
| 110 | MP0001853_heart_inflammation | 0.76784169 |
| 111 | MP0002086_abnormal_extraembryonic_tissu | 0.76141536 |
| 112 | MP0003795_abnormal_bone_structure | 0.76127124 |
| 113 | MP0003077_abnormal_cell_cycle | 0.75201593 |
| 114 | MP0003984_embryonic_growth_retardation | 0.74906515 |
| 115 | MP0002088_abnormal_embryonic_growth/wei | 0.74883005 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.74632217 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.73298822 |
| 118 | MP0000604_amyloidosis | 0.72596122 |
| 119 | MP0000343_altered_response_to | 0.72022914 |
| 120 | MP0000003_abnormal_adipose_tissue | 0.71855575 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.71853115 |
| 122 | MP0010630_abnormal_cardiac_muscle | 0.70903547 |
| 123 | MP0005360_urolithiasis | 0.70503688 |
| 124 | MP0008438_abnormal_cutaneous_collagen | 0.69991819 |
| 125 | MP0001986_abnormal_taste_sensitivity | 0.68834265 |
| 126 | MP0006054_spinal_hemorrhage | 0.64951005 |
| 127 | MP0008874_decreased_physiological_sensi | 0.64949359 |
| 128 | MP0002254_reproductive_system_inflammat | 0.64828505 |
| 129 | MP0009763_increased_sensitivity_to | 0.64083180 |
| 130 | MP0005409_darkened_coat_color | 0.63920232 |
| 131 | MP0002132_abnormal_respiratory_system | 0.63663187 |
| 132 | MP0005595_abnormal_vascular_smooth | 0.61095600 |
| 133 | MP0000470_abnormal_stomach_morphology | 0.60439468 |
| 134 | MP0000920_abnormal_myelination | 0.59566894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 4.26917009 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.91416156 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 3.81180114 |
| 4 | Optic neuritis (HP:0100653) | 3.81180114 |
| 5 | Stomatitis (HP:0010280) | 3.64672450 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.59518748 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 3.52213858 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.37908901 |
| 9 | Increased IgE level (HP:0003212) | 3.33884682 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.27116982 |
| 11 | Cerebral aneurysm (HP:0004944) | 3.24168137 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.15806978 |
| 13 | Abnormality of the fingertips (HP:0001211) | 3.14982001 |
| 14 | Dysostosis multiplex (HP:0000943) | 3.13861140 |
| 15 | Cellulitis (HP:0100658) | 3.06522573 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 2.93788991 |
| 17 | Keratoconjunctivitis sicca (HP:0001097) | 2.91369345 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88526537 |
| 19 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.87881407 |
| 20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.87881407 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 2.87881407 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.82861357 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.82861357 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.82861357 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82114216 |
| 26 | Pustule (HP:0200039) | 2.79543902 |
| 27 | Recurrent fungal infections (HP:0002841) | 2.78970795 |
| 28 | Abnormality of macrophages (HP:0004311) | 2.75688143 |
| 29 | Keratoconjunctivitis (HP:0001096) | 2.74611387 |
| 30 | Mucopolysacchariduria (HP:0008155) | 2.72748511 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.72748511 |
| 32 | Recurrent viral infections (HP:0004429) | 2.70907937 |
| 33 | Myocardial infarction (HP:0001658) | 2.70386948 |
| 34 | Colitis (HP:0002583) | 2.67772439 |
| 35 | Periodontitis (HP:0000704) | 2.64018779 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 2.60473763 |
| 37 | Gingivitis (HP:0000230) | 2.58422970 |
| 38 | Hemoptysis (HP:0002105) | 2.52854829 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.47516618 |
| 40 | Global brain atrophy (HP:0002283) | 2.42348881 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.39776643 |
| 42 | Encephalitis (HP:0002383) | 2.38904291 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.35374328 |
| 44 | Loss of speech (HP:0002371) | 2.35370868 |
| 45 | Disinhibition (HP:0000734) | 2.32772572 |
| 46 | Osteomyelitis (HP:0002754) | 2.30134539 |
| 47 | Hematochezia (HP:0002573) | 2.29319986 |
| 48 | Axonal loss (HP:0003447) | 2.28983811 |
| 49 | Amyloidosis (HP:0011034) | 2.28576304 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.28425546 |
| 51 | Ulnar bowing (HP:0003031) | 2.28416157 |
| 52 | Peritonitis (HP:0002586) | 2.26911108 |
| 53 | Epistaxis (HP:0000421) | 2.25050522 |
| 54 | T lymphocytopenia (HP:0005403) | 2.21401466 |
| 55 | Chronic otitis media (HP:0000389) | 2.20992780 |
| 56 | Hypochromic anemia (HP:0001931) | 2.20764681 |
| 57 | Recurrent skin infections (HP:0001581) | 2.20552572 |
| 58 | Chest pain (HP:0100749) | 2.18846802 |
| 59 | Asymmetric septal hypertrophy (HP:0001670) | 2.17599325 |
| 60 | Upper motor neuron abnormality (HP:0002127) | 2.14661389 |
| 61 | Abnormality of T cell number (HP:0011839) | 2.13978292 |
| 62 | Emphysema (HP:0002097) | 2.12422229 |
| 63 | Episodic fever (HP:0001954) | 2.12233583 |
| 64 | Thick nail (HP:0001805) | 2.11587524 |
| 65 | Thoracic kyphosis (HP:0002942) | 2.07724421 |
| 66 | Neurofibrillary tangles (HP:0002185) | 2.07703933 |
| 67 | Petechiae (HP:0000967) | 2.06669074 |
| 68 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06178735 |
| 69 | Osteolytic defects of the hand bones (HP:0009699) | 2.06178735 |
| 70 | Urethral obstruction (HP:0000796) | 2.05402814 |
| 71 | Spondylolisthesis (HP:0003302) | 2.04879151 |
| 72 | Hypochromic microcytic anemia (HP:0004840) | 2.02985730 |
| 73 | Increased serum ferritin (HP:0003281) | 2.01098463 |
| 74 | Myositis (HP:0100614) | 2.01087053 |
| 75 | Agammaglobulinemia (HP:0004432) | 2.00019983 |
| 76 | Obstructive sleep apnea (HP:0002870) | 1.99950338 |
| 77 | Verrucae (HP:0200043) | 1.99668254 |
| 78 | Papilloma (HP:0012740) | 1.99668254 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 1.99036413 |
| 80 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.96762072 |
| 81 | Purpura (HP:0000979) | 1.93700343 |
| 82 | Arterial thrombosis (HP:0004420) | 1.92599981 |
| 83 | Gingival bleeding (HP:0000225) | 1.92385362 |
| 84 | Agnosia (HP:0010524) | 1.90977787 |
| 85 | Gangrene (HP:0100758) | 1.89622802 |
| 86 | Pulmonary embolism (HP:0002204) | 1.88851445 |
| 87 | Increased CSF protein (HP:0002922) | 1.87109709 |
| 88 | Abnormal platelet function (HP:0011869) | 1.86666926 |
| 89 | Impaired platelet aggregation (HP:0003540) | 1.86666926 |
| 90 | Spontaneous hematomas (HP:0007420) | 1.86442124 |
| 91 | IgM deficiency (HP:0002850) | 1.86149067 |
| 92 | Abnormality of the thoracic spine (HP:0100711) | 1.85921684 |
| 93 | Frequent falls (HP:0002359) | 1.85799466 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 1.85618614 |
| 95 | Mitral stenosis (HP:0001718) | 1.85407830 |
| 96 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85370678 |
| 97 | Obstructive lung disease (HP:0006536) | 1.85370678 |
| 98 | Acne (HP:0001061) | 1.85278340 |
| 99 | Hand muscle atrophy (HP:0009130) | 1.85164307 |
| 100 | Recurrent bronchitis (HP:0002837) | 1.85132107 |
| 101 | Malnutrition (HP:0004395) | 1.84892379 |
| 102 | Abnormality of the pericardium (HP:0001697) | 1.80887423 |
| 103 | Restrictive lung disease (HP:0002091) | 1.80154860 |
| 104 | Long eyelashes (HP:0000527) | 1.80137522 |
| 105 | Sepsis (HP:0100806) | 1.79655512 |
| 106 | Broad face (HP:0000283) | 1.79203770 |
| 107 | Meningitis (HP:0001287) | 1.79152855 |
| 108 | Microcytic anemia (HP:0001935) | 1.79001861 |
| 109 | Hypergammaglobulinemia (HP:0010702) | 1.78509359 |
| 110 | Cerebral inclusion bodies (HP:0100314) | 1.78401737 |
| 111 | Anorexia (HP:0002039) | 1.77666417 |
| 112 | Pathologic fracture (HP:0002756) | 1.77421038 |
| 113 | Vasculitis (HP:0002633) | 1.77030836 |
| 114 | Prominent nose (HP:0000448) | 1.76755036 |
| 115 | Increased density of long bones (HP:0006392) | 1.76629743 |
| 116 | Leukocytosis (HP:0001974) | 1.74924505 |
| 117 | Slow saccadic eye movements (HP:0000514) | 1.74115638 |
| 118 | Milia (HP:0001056) | 1.73978513 |
| 119 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.73539336 |
| 120 | Abnormality of the endocardium (HP:0004306) | 1.73105924 |
| 121 | Upper limb amyotrophy (HP:0009129) | 1.72509900 |
| 122 | Distal upper limb amyotrophy (HP:0007149) | 1.72509900 |
| 123 | Gastrointestinal stroma tumor (HP:0100723) | 1.71404852 |
| 124 | Aortic aneurysm (HP:0004942) | 1.67401175 |
| 125 | Esophageal varix (HP:0002040) | 1.67310280 |
| 126 | Recurrent cutaneous fungal infections (HP:0011370) | 1.67073452 |
| 127 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.67073452 |
| 128 | Aneurysm (HP:0002617) | 1.66582069 |
| 129 | Hyperacusis (HP:0010780) | 1.66054149 |
| 130 | Glomerulonephritis (HP:0000099) | 1.65549810 |
| 131 | Cheilitis (HP:0100825) | 1.65456728 |
| 132 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.65111415 |
| 133 | Abnormality of the nasal mucosa (HP:0000433) | 1.65081880 |
| 134 | Nasal polyposis (HP:0100582) | 1.64244117 |
| 135 | Orchitis (HP:0100796) | 1.64088320 |
| 136 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.64086318 |
| 137 | Coarse hair (HP:0002208) | 1.64017489 |
| 138 | Prolonged bleeding time (HP:0003010) | 1.63849881 |
| 139 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.62188069 |
| 140 | Heterotopia (HP:0002282) | 1.62160902 |
| 141 | Lymphopenia (HP:0001888) | 1.62103704 |
| 142 | Urticaria (HP:0001025) | 1.61828933 |
| 143 | Polycythemia (HP:0001901) | 1.61575626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.62712394 |
| 2 | MAP4K1 | 3.45351680 |
| 3 | ERN1 | 3.37372856 |
| 4 | TRIB3 | 3.02693879 |
| 5 | CAMK1D | 2.87440198 |
| 6 | MAP3K10 | 2.50242210 |
| 7 | PRPF4B | 2.41861865 |
| 8 | CAMK1G | 2.19980465 |
| 9 | PKN2 | 2.19338594 |
| 10 | SIK2 | 2.03605977 |
| 11 | TYK2 | 1.88749844 |
| 12 | MAP2K3 | 1.87664835 |
| 13 | EEF2K | 1.85247711 |
| 14 | STK10 | 1.84531178 |
| 15 | SIK1 | 1.77514624 |
| 16 | TAOK2 | 1.73625069 |
| 17 | TTN | 1.69193251 |
| 18 | KIT | 1.65181998 |
| 19 | NEK2 | 1.60327657 |
| 20 | TNK2 | 1.55454354 |
| 21 | TGFBR2 | 1.51468408 |
| 22 | CSF1R | 1.45457256 |
| 23 | BLK | 1.44452707 |
| 24 | GRK6 | 1.43332575 |
| 25 | JAK1 | 1.42001570 |
| 26 | TBK1 | 1.41227504 |
| 27 | TAOK3 | 1.40246854 |
| 28 | PTK6 | 1.35690535 |
| 29 | CDC42BPA | 1.33121079 |
| 30 | ZAP70 | 1.32746040 |
| 31 | RIPK1 | 1.31905853 |
| 32 | EPHB1 | 1.30737766 |
| 33 | HCK | 1.30575214 |
| 34 | BRD4 | 1.30163852 |
| 35 | CDK6 | 1.30015411 |
| 36 | MARK2 | 1.29393423 |
| 37 | RIPK4 | 1.27545192 |
| 38 | MARK3 | 1.25631426 |
| 39 | FGFR4 | 1.23214890 |
| 40 | MAP3K1 | 1.22929930 |
| 41 | JAK3 | 1.18164939 |
| 42 | MTOR | 1.14128623 |
| 43 | IRAK3 | 1.13357618 |
| 44 | TAOK1 | 1.12478106 |
| 45 | CSK | 1.11984982 |
| 46 | CDK4 | 1.10420401 |
| 47 | RPS6KA4 | 1.09591396 |
| 48 | LRRK2 | 1.09485395 |
| 49 | FGFR3 | 1.06430659 |
| 50 | PIM1 | 1.03243708 |
| 51 | SYK | 1.01398518 |
| 52 | IRAK1 | 1.01147948 |
| 53 | STK3 | 1.00961447 |
| 54 | STK4 | 0.96589651 |
| 55 | PAK4 | 0.96488946 |
| 56 | ALK | 0.95649603 |
| 57 | MAP3K13 | 0.93403929 |
| 58 | BTK | 0.90284222 |
| 59 | SGK3 | 0.89411882 |
| 60 | EPHA2 | 0.89117672 |
| 61 | ICK | 0.88422524 |
| 62 | CHUK | 0.86860565 |
| 63 | PTK2B | 0.85931037 |
| 64 | MAP3K6 | 0.85107969 |
| 65 | IKBKB | 0.84933959 |
| 66 | MAP2K6 | 0.84772989 |
| 67 | LATS1 | 0.84329128 |
| 68 | GRK7 | 0.83571484 |
| 69 | HIPK2 | 0.82871988 |
| 70 | BMX | 0.82842192 |
| 71 | JAK2 | 0.81663445 |
| 72 | MAP3K2 | 0.81310096 |
| 73 | MAPK7 | 0.81172844 |
| 74 | MAP3K3 | 0.79629358 |
| 75 | FES | 0.77899129 |
| 76 | TRPM7 | 0.77312960 |
| 77 | RPS6KA2 | 0.76678629 |
| 78 | CDK9 | 0.76649830 |
| 79 | NEK9 | 0.75616298 |
| 80 | IKBKE | 0.74537156 |
| 81 | RPS6KL1 | 0.73978350 |
| 82 | RPS6KC1 | 0.73978350 |
| 83 | ITK | 0.73899480 |
| 84 | EPHA3 | 0.73386257 |
| 85 | RPS6KA6 | 0.73042366 |
| 86 | PRKCH | 0.71948504 |
| 87 | MAP3K8 | 0.71313797 |
| 88 | MAP3K11 | 0.69860455 |
| 89 | IRAK2 | 0.69723990 |
| 90 | WNK1 | 0.68846708 |
| 91 | KSR2 | 0.68200978 |
| 92 | LCK | 0.67482223 |
| 93 | PDGFRB | 0.62732276 |
| 94 | PRKAA2 | 0.60002603 |
| 95 | DAPK2 | 0.59431466 |
| 96 | MAPK11 | 0.59114707 |
| 97 | MAP3K14 | 0.58840622 |
| 98 | DMPK | 0.56675876 |
| 99 | EGFR | 0.55759898 |
| 100 | LYN | 0.54417631 |
| 101 | CAMKK2 | 0.53676896 |
| 102 | SGK2 | 0.53507758 |
| 103 | MAP3K5 | 0.51716035 |
| 104 | IRAK4 | 0.51323248 |
| 105 | TXK | 0.51278170 |
| 106 | SIK3 | 0.50667926 |
| 107 | CAMKK1 | 0.48135013 |
| 108 | TTK | 0.47966501 |
| 109 | CLK1 | 0.47552790 |
| 110 | DDR2 | 0.47277719 |
| 111 | STK38 | 0.46583169 |
| 112 | PTK2 | 0.46453718 |
| 113 | TEC | 0.46189910 |
| 114 | PIK3CG | 0.45286497 |
| 115 | ABL1 | 0.44606064 |
| 116 | PDK1 | 0.44254267 |
| 117 | FYN | 0.43635068 |
| 118 | CDK7 | 0.42596013 |
| 119 | PRKCQ | 0.41754530 |
| 120 | MAP3K7 | 0.41521742 |
| 121 | MATK | 0.41233227 |
| 122 | BMPR2 | 0.40856664 |
| 123 | MOS | 0.40645489 |
| 124 | PDGFRA | 0.40135805 |
| 125 | MAPKAPK2 | 0.40132413 |
| 126 | FGR | 0.39905445 |
| 127 | PRKAA1 | 0.38938465 |
| 128 | RET | 0.38710315 |
| 129 | STK11 | 0.38514163 |
| 130 | MAPK12 | 0.37978889 |
| 131 | CAMK4 | 0.37396412 |
| 132 | PDPK1 | 0.37037262 |
| 133 | DYRK1B | 0.36856559 |
| 134 | PAK2 | 0.36450567 |
| 135 | SCYL2 | 0.34619973 |
| 136 | ATR | 0.34187403 |
| 137 | FLT3 | 0.34021812 |
| 138 | PRKD2 | 0.33743098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.65130030 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.56121054 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29892374 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22298763 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.17889077 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02901407 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87650171 |
| 8 | Lysine degradation_Homo sapiens_hsa00310 | 1.79893990 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79735483 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77684141 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.77010032 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73320423 |
| 13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.71880251 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69566051 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.65330825 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.60174281 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54469980 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.52126645 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.50331412 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46623039 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.33901370 |
| 22 | Apoptosis_Homo sapiens_hsa04210 | 1.33235621 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28891734 |
| 24 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.28690136 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27680686 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26034010 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24947986 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.23947611 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18870820 |
| 30 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18554278 |
| 31 | Insulin resistance_Homo sapiens_hsa04931 | 1.18525212 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16473075 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16416025 |
| 34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13915645 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.13470619 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12936906 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11803396 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.11422858 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10650396 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09252444 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.07582066 |
| 42 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06078893 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05760872 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.02736238 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02599917 |
| 46 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.00481739 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00015050 |
| 48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99942464 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 0.97861878 |
| 50 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.96027665 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.94073301 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91432414 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.91256567 |
| 54 | Malaria_Homo sapiens_hsa05144 | 0.91203841 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.90848169 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90501159 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88601640 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88377125 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87635467 |
| 60 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.87139643 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87066937 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86973970 |
| 63 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86056797 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85975713 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85915253 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85812871 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85618817 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85036674 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83851613 |
| 70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.83834453 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83160292 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82915848 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.82493882 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81214768 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79909747 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79505198 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79331745 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78944480 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78702460 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76826969 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76668963 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74629078 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.74515270 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.73687165 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73515749 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73148576 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73063049 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.72058552 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70465044 |
| 90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70286817 |
| 91 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70257790 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69891959 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69134384 |
| 94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69084353 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68081431 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.67625268 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67058052 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66361225 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64030510 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.62935534 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61583277 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60599293 |
| 103 | Glioma_Homo sapiens_hsa05214 | 0.60539066 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.60404982 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.60250477 |
| 106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.60164356 |
| 107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59844140 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59401657 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58497488 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56570276 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.56488245 |
| 112 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56207155 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54996805 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.54522791 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53934801 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52641096 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52370053 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52053286 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50463100 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.49812242 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49807611 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49141025 |
| 123 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48416714 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45345283 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44438784 |
| 126 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43648342 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40322066 |

